230 results on '"Myung, S. J."'
Search Results
2. P1069 One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study
3. P259 Clinical characteristics and long-term disease course in patients with Crohn’s disease diagnosed by video capsule endoscopy; A retrospective multicentre matched case-control study
4. P525 Utilisation of endoscopic ultrasonography for submucosal cushion measurement to determine eligibility for endoscopic submucosal dissection in ulcerative colitis-associated dysplasia: A case series
5. P334 The longitudinal analysis of fecal microbiota in response to ustekinumab treatment in patients with Crohn’s disease
6. P239 Characteristics and outcomes of portal vein thrombosis in patients with Inflammatory Bowel Disease in Korea
7. P585 Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
8. Endoscopists’ expertise level as a factor influencing clinical outcomes after bridge-to-surgery stenting in obstructive colorectal cancer
9. P762 Population Pharmacokinetic Model of Intravenous Infliximab in Korean Patients with Crohn’s Disease
10. P659 Continuing or stopping 5-aminosalicylate in patients with Inflammatory Bowel Disease under anti-TNF therapy: A nationwide population-based study
11. P143 Outcomes of ulcerative colitis-associated dysplasia patients treated with endoscopic submucosal dissection: An extended analysis of a single center cohort
12. Biofeedback Therapy ☆
13. P641 Long-term outcome of adalimumab therapy and predictors of response in 254 patients with Crohnʼs disease: a hospital-based cohort study from Korea
14. P482 Early anti-TNF/immunomodulator therapy is associated with better clinical outcomes in Asian patients with Crohnʼs disease with poor prognostic factors
15. P406 Clinical correlations of infliximab trough levels and antibodies to infliximab in Korean patients with Crohnʼs disease
16. P252 Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients Crohnʼs disease
17. P148 Fecal calprotectin as a noninvasive indicator for ulcerative colitis disease activity in the Korean cohort
18. P090 Metformin induces late Apoptosis and modulates dysbiosis in western-style diet induced colitic cancer
19. P448 Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
20. P722 Compositional differences of gut microbiome using taxonomic profiling in patients with ulcerative colitis after treatment with vedolizumab
21. P560 Application of a clinical decision support tool for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicenter study
22. Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-up
23. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial
24. The effect of age on the key parameters in the Chicago classification: a study using high-resolution esophageal manometry in asymptomatic normal individuals
25. Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report
26. A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: A report of the Rome Foundation Working Team on cross-cultural, multinational research
27. Validation of the EQ-5D questionnaire in Female Patients with Chronic Constipation in a Tertiary Care Center: PP195
28. Gender differences on high-resolution anorectal manometry findings in patients with chronic constipation: PP124
29. Diagnostic value of digital rectal examination in patients with defecatory dyssynergia compared to highresolution anorectal manometry: PP122
30. Prevalence of fructose malabsorption in patients with irritable bowel syndrome after excluding small intestinal bacterial overgrowth: PP102
31. New high-resolution anorectal manometry parameter for predicting balloon expulsion in an asymptomatic normal population on the basis of a three-dimensional integrated pressurized volume of spatiotemporal plot: OP024*
32. Normal values for high-resolution anorectal manometry: Authorʼs Reply
33. Normal values for high-resolution anorectal manometry/topography in a healthy Korean population and the effects of gender and body mass index
34. Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis
35. Primary Colon Lymphoma in Korea: A KASID (Korean Association for the Study of Intestinal Diseases) Study
36. Biofeedback Therapy
37. Three-dimensional volume of inverted impedance(3D-VII): A novel method to measure bolus transit using high-resolution impedance manometry: 002
38. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine
39. P348 Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study
40. P782 Immune status to viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
41. P803 The risk of spine and hip fracture in patients with inflammatory bowel diseases: a nationwide population-based study
42. P274 The clinical significance of anastomotic ulcers after ileocolic resection to predict postoperative recurrence of Crohn’s disease
43. The gastrointestinal function and biofeedback therapy response in constipated patients after radical hysterectomy and delivery: 127
44. Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients
45. P319 Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy
46. P759 Incidence and clinical impact of perianal disease in patients with ulcerative colitis: a nationwide population-based study
47. DOP65 The association of faecal calprotectin level and combined mucosal and transmural healing in patients with Crohn’s disease
48. P726 Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on infliximab maintenance therapy
49. P277 Real life effectiveness and safety of vedolizumab induction and maintenance therapy for Korean IBD patients in whom anti-TNF treatment failed: a prospective cohort study
50. A high-resolution anorectal manometry parameter based on integrated pressurized volume: A study based on 204 male patients with constipation and 26 controls
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.